Meta-Analysis: Reduced Risk of Anxiety with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder

被引:46
作者
Coughlin, Catherine G. [1 ]
Cohen, Stephanie C. [1 ]
Mulqueen, Jilian M. [1 ]
Ferracioli-Oda, Eduardo [2 ]
Stuckelman, Zachary D. [1 ]
Bloch, Michael H. [1 ,3 ]
机构
[1] Yale Univ, Sch Med, Yale Child Study Ctr, New Haven, CT 06520 USA
[2] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil
[3] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA
基金
美国国家卫生研究院;
关键词
DEFICIT-HYPERACTIVITY DISORDER; SLI381 ADDERALL XR; DOUBLE-BLIND; PRESCHOOL-CHILDREN; CLINICAL-RESPONSE; METHYLPHENIDATE; PLACEBO; EFFICACY; SAFETY; SUBTYPES;
D O I
10.1089/cap.2015.0075
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: Anxiety is a commonly reported side-effect of psychostimulant treatment. Our goal was to quantify the risk of anxiety as a side effect of psychostimulant treatment for attention-deficit/hyperactivity disorder (ADHD). Methods: We conducted a PubMed search to identify all double-blind, randomized, placebo-controlled trials examining the efficacy of psychostimulant medications in the treatment of children with ADHD. We used a fixed-effects meta-analysis to examine the risk ratio of anxiety reported as a side effect in children treated with psychostimulants compared with those treated with placebo. We used stratified subgroup analysis and meta-regression to examine the effects of stimulant type, dosage, duration of use, and trial design on the measured risk of anxiety. Results: We identified 23 studies involving 2959 children with ADHD for inclusion in our meta-analysis. The risk of anxiety associated with psychostimulant treatment was significantly lower than that experienced with placebo (relative risk [RR]=0.86 [95% CI: 0.77, 0.95], z=-2.90, p<0.05). Higher doses of psychostimulants were associated with a reduced measured risk of anxiety of psychostimulants when compared with placebo (=-0.0039 [95% CI: -0.00718, -0.00064], z=-2.34, p=0.019). Conclusions: Meta-analysis suggests that treatment with psychostimulants significantly reduced the risk of anxiety when compared with placebo. This finding does not rule out the possibility that some children experience increased anxiety when treated with psychostimulants, but suggests that those risks are outweighed by the number of children who experience improvement in anxiety symptoms (possibly as a secondary effect of improved control of ADHD symptoms). Clinicians should consider rechallenging children with ADHD who report new-onset or worsening anxiety with psychostimulants, as these symptoms are much more likely to be coincidental rather than caused by psychostimulants.
引用
收藏
页码:611 / 617
页数:7
相关论文
共 40 条
  • [1] Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders
    Abikoff, H
    McGough, J
    Vitiello, B
    McCracken, J
    Dames, M
    Walkup, J
    Riddle, M
    Oatis, M
    Greenhill, L
    Skrobala, A
    March, J
    Gammon, P
    Robinson, J
    Lazell, R
    McMahon, DJ
    Ritz, L
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2005, 44 (05) : 418 - 427
  • [2] AHMANN PA, 1993, PEDIATRICS, V91, P1101
  • [3] [Anonymous], PROD INF QUILLIVANT
  • [4] [Anonymous], ADDERALL XR R OR CAP
  • [5] [Anonymous], J ATTEN DISORD
  • [6] BARKLEY RA, 1990, PEDIATRICS, V86, P184
  • [7] A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder
    Biederman, J
    Lopez, FA
    Boellner, SW
    Chandler, MC
    [J]. PEDIATRICS, 2002, 110 (02) : 258 - 266
  • [8] mCPP-induced anxiety in the light-dark box in rats -: a new method for screening anxiolytic activity
    Bilkei-Gorzó, A
    Gyertyán, I
    Lévay, G
    [J]. PSYCHOPHARMACOLOGY, 1998, 136 (03) : 291 - 298
  • [9] PREDICTION OF CLINICAL-RESPONSE TO METHYLPHENIDATE IN CHILDREN WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER
    BUITELAAR, JK
    VANDERGAAG, RJ
    SWAABBARNEVELD, H
    KUIPER, M
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1995, 34 (08) : 1025 - 1032
  • [10] Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects
    Buitelaar, JK
    vanderGaag, RJ
    SwaabBarneveld, H
    Kuiper, M
    [J]. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 1996, 37 (05) : 587 - 595